Therapeutic angiogenesis as an advanced direction for potentiating the angiogenic effect of coronary artery bypass grafting-Reference-Cited by-同舟云学术

Therapeutic angiogenesis as an advanced direction for potentiating the angiogenic effect of coronary artery bypass grafting

Published:2023-03-16 Issue:1 Volume:12 Page:118-128
ISSN:2587-9537
Container-title:Complex Issues of Cardiovascular Diseases
language:
Short-container-title:Kompleks. probl. serdečno-sosud. zabol.

Author:

Oleynik B. A.¹^ORCID,Plechev V. V.¹^ORCID,Starodobov V. I.²^ORCID,Evdakov V. A.²^ORCID,Izhbuldin R. I.¹^ORCID

Affiliation:

1. Federal State Budgetary Educational Institution of Higher Educational “Bashkir State Medical University” of the Ministry of Healthcare of the Russian Federation

2. Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian Federation

Abstract

Highlights. This review systematizes the results of experimental and clinical studies on the impact of coronary artery bypass grafting on angiogenesis and potential use of pyrimidine derivatives for therapeutic angiogenesis.Abstract. Coronary artery bypass grafting is the preferred treatment modality for multivessel coronary artery disease. However, the clinical efficacy of the procedure decreases over time due to the progression of atherosclerosis in the bypass grafts and native coronary arteries. In this regard, it is of great scientific and practical interest to disclose the mechanisms affecting the development of the microvasculature during myocardial surgical revascularization, as well as the search for pharmacological substances capable of stimulating the process of angiogenesis during these surgeries to improve short and long-term outcomes. The article presents a review of experimental and clinical studies on the effect of coronary artery bypass surgery on angiogenesis and highlights the place of pyrimidine derivatives in therapeutic angiogenesis in coronary artery disease.

Publisher

NII KPSSZ

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Rehabilitation,Emergency Medicine,Surgery

Reference57 articles.

1. Gaudino M., Hameed I., Farkouh M. E., Rahouma M., Naik A., Robinson N.B., Ruan Y., Demetres M., Biondi-Zoccai G., Angiolillo D.J., Bagiella E., Charlson M.E., Benedetto U., Ruel M., Taggart D.P., Girardi L.N., Bhatt D.L., Fremes S.E. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis. JAMA Internal Medicine. 2020;180:1638–1646. doi: 10.1001/jamainternmed.2020.4748.

2. Doenst T., Haverich A., Serruys P., Bonow R.O., Kappetein P., Falk V., Velazquez E., Diegeler A., Sigusch H. PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. Journal of the American College of Cardiology. 2019;73:964–9. doi: 10.1016/j.jacc.2018.11.053

3. Glineur D., Rahouma M., Grau J.B., Etienne P.Y., Fortier J.H., Papadatos S., Laruelle C., Pieters D., El Khoury E., Gaudino M. FFR Cutoff by Arterial Graft Configuration and Location. JACC: Cardiovascular Interventions. 2020;13(1):143–4. doi: 10.1016/j.jcin.2019.08.013

4. Spadaccio C., Antoniades C., Nenna A., Chung C., Will R., Chello M., Gaudino M.F.L. Preventing treatment failures in coronary artery disease: What can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries? Cardiovascular Research. 2020; 116(3): 505–519. doi: 10.1093/cvr/cvz214

5. Allahwala U.K., Khachigian L.M., Nour D., Ridiandres A, Billah M., Ward M., Weaver J., Bhindi R. Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis. Microvascular Research. 2020;132:104058. doi: 10.1016/j.mvr.2020.104058